Central Council for Research in Ayurvedic Sciences Launches PRAGATI-2024 (GS Paper 2, Policies)
Introduction:
- The Central Council for Research in Ayurvedic Sciences (CCRAS), under the Ministry of Ayush, Government of India, is organizing the "Pharma Research in AyurGyan And Techno Innovation (PRAGATI-2024)" event at the India Habitat Centre, New Delhi, on May 28, 2024.
- This collaborative initiative aims to propel Ayurveda research and industry by fostering partnerships between CCRAS and the Ayurvedic drug sector.
Key Participants:
- The program will be inaugurated by Secretary Ministry of Ayush, Vd. Rajesh Kotecha, who will deliver a keynote speech on the role of industry in Ayurveda development.
- Mrs. Kavita Garg, Joint Secretary, and Dr. Koustubha Upadhaya, Advisor, Ministry of Ayush, will also participate in the event.
- Prof. Vaidya Rabinarayan Acharya, Director General of CCRAS, will lead the meeting, emphasizing the importance of research-based, quality Ayurvedic products.
Objectives of PRAGATI-2024:
The event aims to:
- Utilize CCRAS's research outcomes and technologies.
- Establish collaborative networks for research and development.
- Identify potential industrial partners for collaboration.
- Explore opportunities for capacity building and entrepreneurship in Ayurvedic pharmaceutics.
Technical Sessions:
The event features four specialized technical sessions:
1. Highlighting CCRAS's product development initiatives and strategies for researcher-industry collaborations.
2. Panel discussion on regional and global Ayurveda drug development.
3. Experience sharing and industry expectations from CCRAS.
4. Focused group discussions on setting research priorities for CCRAS-industry collaboration.
Industry Participation:
- Representatives from 35 pharmaceutical companies, including CEOs from renowned firms such as Himalaya, Emami, Baidyanath, Dabur, and others, will participate.
- Experts from organizations like CII, Ayush Excil, PCIMH, and NRDC will also attend.
Expected Outcome:
- PRAGATI-2024 aims to identify potential industrial partners, exchange scientific knowledge, and utilize research outcomes in Ayurvedic drug development.
- This initiative will enhance networking, institutional linkages, and benefit Ayurvedic clinicians and patients alike.
